Results 1 to 10 of about 221,497 (291)
Bereitschaftspotential in Multiple System Atrophy [PDF]
Frontiers in Neurology, 2021 Objective: Multiple system atrophy (MSA) is a neurodegenerative disorder manifesting as parkinsonism, cerebellar ataxia, and autonomic dysfunction. It is categorized into MSA with predominant parkinsonism (MSA-P) and into MSA with predominant cerebellar ...
Yi-Chien Yang +16 more
doaj +3 more sources
Multiple system atrophy: diagnostic methods and biomarkers [PDF]
Анналы клинической и экспериментальной неврологии, 2022 Multiple system atrophy (MSA) is a neurodegenerative disease belonging to a group of synucleinopathies and characterized by significant autonomic failure, parkinsonian syndrome, and cerebellar signs.
Maksim N. Andreev +1 more
doaj +2 more sources
Inflammation in multiple system atrophy
Frontiers in Immunology, 2023 Misfolding protein aggregation inside or outside cells is the major pathological hallmark of several neurodegenerative diseases. Among proteinopathies are neurodegenerative diseases with atypical Parkinsonism and an accumulation of insoluble fibrillary ...
Marta Leńska-Mieciek +5 more
doaj +3 more sources
S.S. Korsakov Journal of Neurology and Psychiatry, 2023 The article presents a progressive neurodegenerative disease — multisystem atrophy, characterized by a combination of autonomic failure and various motor disorders, including parkinsonism and/or cerebellar ataxia; etiopathogenetic factors and variants of the clinical picture are described.
M.P. Topuzova +8 more
core +8 more sources
A case of multiple system atrophy [PDF]
Journal of International Medical Research, 2019 Multiple system atrophy (MSA) is the most rapidly progressive neurodegenerative disorder among the various types of synucleinopathies. The cause of MSA remains unknown, but it can involve the extrapyramidal system, the pyramidal system, the autonomic ...
Jing Guo +4 more
doaj +3 more sources
Posterior fossa arachnoid cysts in multiple system atrophy [PDF]
IBRO Neuroscience ReportsBackground: Multiple system atrophy (MSA) is an α-synucleinopathy characterized by prominent cerebellar or parkinsonian features. This is pathologically due to the deposition of α-synuclein in glial cells, the mechanism by which s not entirely clear.
Audrey M. Blazek Ramsay, M.D +3 more
doaj +2 more sources
Tremor in Multiple System Atrophy - a review
Tremor and Other Hyperkinetic Movements, 2013 Background: Multiple system atrophy (MSA) is a rare neurodegenerative movement disorder characterized by a rapidly progressive course. The clinical presentation can include autonomic failure, parkinsonism, and cerebellar signs.
Christine Kaindlstorfer +2 more
doaj +5 more sources
Physical Therapy, 1999 Multiple system atrophy is a neurological disorder that has gone unrecognized for too long due to its involvement across multiple regions of the central nervous system. This disorder is finally being unveiled through increased reporting in the scientific literature.
L, Swan, J, Dupont
+7 more sources
Seminars in Neurology, 2001 Multiple system atrophy (MSA) is an adult-onset sporadic progressive neurodegenerative disorder of unknown etiology. It is clinically characterized by the variable combination of autonomic failure, parkinsonism, cerebellar ataxia, and pyramidal signs. The present review summarizes up-to-date knowledge on the clinical diagnosis and molecular pathology ...
G K, Wenning +4 more
+7 more sources
Frontiers in Neurology, 2022 Multiple system atrophy (MSA) is a rare and progressive neurodegenerative disorder. Autonomic failure (AF) is one main clinical feature which has a significant impact on health-related quality of life.
Marc Kermorgant +13 more
doaj +1 more source